Patents Assigned to Oncgnostics GmbH
  • Patent number: 9228238
    Abstract: A method for the early diagnosis of carcinomas of the anogenital tract, preferably of the cervical carcinoma, and the preliminary stages thereof is described. The method is based on the determination of the methylation status of segments of the gene regions of ASTN1 (astrotactin 1) and ZNF671 (zinc finger protein 671, transcription factor). A DNA methylation in the promoter region or the 5?-region of these genes is indicative for carcinomas of the anogenital tract or severe preliminary stages thereof. The present invention also relates to kits which permit the conduction of the diagnostic method according to the invention.
    Type: Grant
    Filed: August 29, 2013
    Date of Patent: January 5, 2016
    Assignee: ONCGNOSTICS GMBH
    Inventors: Matthias Dürst, Alfred Hansel, Daniel Steinbach
  • Publication number: 20130344479
    Abstract: A method for the early diagnosis of carcinomas of the anogenital tract, preferably of the cervical carcinoma, and the preliminary stages thereof is described. The method is based on the determination of the methylation status of segments of the gene regions of ASTN1 (astrotactin 1) and ZNF671 (zinc finger protein 671, transcription factor). A DNA methylation in the promoter region or the 5?-region of these genes is indicative for carcinomas of the anogenital tract or severe preliminary stages thereof. The present invention also relates to kits which permit the conduction of the diagnostic method according to the invention.
    Type: Application
    Filed: August 29, 2013
    Publication date: December 26, 2013
    Applicant: Oncgnostics GmbH
    Inventors: Matthias DÜRST, Alfred HANSEL, Daniel STEINBACH
  • Patent number: 8575326
    Abstract: A method for the early diagnosis of carcinomas of the anogenital tract, preferably of the cervical carcinoma, and the preliminary stages thereof is described. The method is based on the determination of the methylation status of segments of the gene regions of ASTN1 (astrotactin 1) and ZNF671 (zinc finger protein 671, transcription factor). A DNA methylation in the promoter region or the 5?-region of these genes is indicative for carcinomas of the anogenital tract or severe preliminary stages thereof. The present invention also relates to kits which permit the conduction of the diagnostic method according to the invention.
    Type: Grant
    Filed: September 17, 2010
    Date of Patent: November 5, 2013
    Assignee: Oncgnostics GmbH
    Inventors: Matthias Dürst, Alfred Hansel, Daniel Steinbach